Research and development - Press Releases

Date	Title	Company
05-Apr-2021	Allergy Treatment Market Worth US$ 35,812.33 Mn by 2028 and to grow at a CAGR of 6.9%	theinsightpartners
05-Apr-2021	Risk Invovled In Clinical Trial for Clinical Research	Clariwell Global Services LLP
01-Apr-2021	Next Generation Sequencing Services Market Size, Global Industry Growth, Key Trends and Forecast 2020-2026 \| iCognition Insights	iCognition Insights
01-Apr-2021	SciBite launches AI-driven semantic search platform to help manage the life science data deluge	SciBite
01-Apr-2021	Medical Perfusion Technology Market by Technology Trends 2021 - XVIVO Perfusion, OrganOx Limited, TransMedics, Organ Recovery Systems, Xenios AG	theinsightpartners
31-Mar-2021	Panthera is running a Ph 3 trial for AstraZeneca’s monoclonal antibody combination to reduce the effects of COVID-19 in patients with the virus from its North Manchester site	Panthera Biopartners
31-Mar-2021	Global Oncology Biosimilar Treatment Market is estimated to be US$ 44439.4 million by 2030 with a CAGR of 57.6% during the forecast period	Prophecy Market Insights
31-Mar-2021	U.S. FDA Accepts AbbVie's New Drug Application for Atogepant for the Preventive Treatment of Migraine	AbbVie
31-Mar-2021	Roche launches Elecsys Epstein-Barr Virus (EBV) immunoassay panel to improve EBV infection staging	Roche
31-Mar-2021	Jazz Pharmaceuticals Announces FDA Approval of Additional Indication for Vyxeos® (daunorubicin and cytarabine) for the Treatment of Secondary Acute Myeloid Leukemia in Pediatric Patients	Jazz Pharmaceuticals
30-Mar-2021	The Pistoia Alliance Tackles Challenges in Data Governance to Advance Digital Transformation in Pharma	Pistoia Alliance
30-Mar-2021	Adrenocorticotropic Hormone (ACTH) Market Report 2021-2031	Visiongain
30-Mar-2021	Roche’s Evrysdi approved by European Commission as first and only at home treatment for spinal muscular atrophy	Roche
30-Mar-2021	Merck Receives Complete Response Letter From US FDA for Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab) in High-Risk Early-Stage Triple-Negative Breast Cancer (TNBC)	Merck
26-Mar-2021	Liver Cancer Therapeutics Market to Cross USD11 billion by 2025 \| TechSci Research	TechSci Research Pvt Ltd
26-Mar-2021	Real-World Evidence Supports Effectiveness of First-Line IBRANCE® (Palbociclib) Combination Therapy in HR+, HER2- Metastatic Breast Cancer	Pfizer
25-Mar-2021	Invite from Jim Polarine and Geeta Singh, Co-Chairs to join Pharmaceutical Microbiology West Coast Virtual Conference	SMi Group
25-Mar-2021	OFWAT & NESTA CHALLENGES CALL ON INNOVATORS IN PHARMACEUTICALS TO COLLABORATE ON £40M WATER CHALLENGE	Seven Consultancy
25-Mar-2021	Key milestone in molded glass: SGD Pharma elevates Type I offering with three tailored product and service solutions	SGD Pharma
25-Mar-2021	Continuous manufacturing μLOT® enabling technology could radically cut industry’s use of toxic chemicals	SB3000